Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 61736 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 74099 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 90877 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 109172 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 145121 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 149274 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 151008 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 190054 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 193482 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | 284585 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M-H)- | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 18076 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 19659 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 21551 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 24989 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 32746 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 36429 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 38478 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 40645 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 41322 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 46518 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 51785 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 54224 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 54919 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 56061 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 57874 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 59722 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | 61604 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+H)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+NA)+ | 1914 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | ASPARTATE (CAS# 56-84-8); (M+NA)+ | Peak area | Severe disease |